MedTech Business - January 29, 2024
Capitainer opens new qDBS microsampling laboratory in US
Capitainer has announced the opening of its new US laboratory, miQro Lab Solutions, in Warwick, Rhode Island. This step reflects the company’s ambition to integrating its advanced self-sampling solutions into the U.S. healthcare system more rapidly, it states. Initially, the new miQro Lab Solutions laboratory will focus on clinical lab services, specializing in lead (Pb) […]
MedTech Business - January 26, 2024
Getinge inaugurates its Global Centre of Excellence for Chemistry
The new centre, which also becomes the UK headquarters, bring together the company’s chemistry and instrument decontamination business. It will be inaugurated on January 31 and is located in the industrial & logistics park St. Modwen Park Derby. During the opening Getinge will showcase the 79’000 sq/ft production, warehouse, laboratory, showroom, training area and office […]
Collaboration - January 25, 2024
Sigrid Therapeutics collaborates with Cencora
Sigrid Therapeutics has entered into an agreement with Cencora aimed at accelerating the commercialization of its SiPore technology. SiPore21 is currently undergoing SHINE clinical trials as an innovative medical device designed for sustained blood sugar and weight control. Administered orally, SiPore21 utilizes a mesoporous silica mineral to prevent digestive enzymes from breaking down carbohydrates and […]
Biotech Business - January 8, 2024
Anocca receives certificate of GMP compliance for its in-house cell therapy manufacturing facility
The manufacturing license paves the way for Anocca’s near-term path to the clinic and long-term strategy to advance franchises of precision targeted cell therapies for different cancers and covering diverse patient populations. Anocca has built validated asset franchises against valuable cancer targets including KRAS, PRAME and MAGE, with more than 40 preclinical assets in the […]
Biotech Business - December 14, 2023
Nykode announces expansion of oncology pipeline
Nykode Therapeutics has announced an expansion of the pipeline with a potential first-in-class preclinical oncology vaccine program aimed at preventing and treating colorectal cancer. “The potential first-in-class program reaffirms Nykode’s vision of building a balanced cancer vaccine portfolio. We are excited about the transformative power of our next-generation technology with the potential to reduce the […]
New Market - November 27, 2023
China NMPA’s approves Calliditas’ Nefecon
Calliditas’ partner Everest Medicines has announced that China’s National Medical Products Administration (NMPA) has approved Nefecon for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression. Everest also announced that, in addition to Nefecon’s approval in mainland China and Macau, it expects a decision on New Drug Application (NDA) […]
